GSA Capital Partners’s cbdMD YCBD Stock Holding History

GSA Capital Partners’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-37,465	Closed	-$33K	–	2170
2025 Q2	$33K	Buy	37,465 +33,495	+844%	+$44K	﹤0.01%	1680
2025 Q1	$7K	Buy	+3,970	New	+$13.9K	﹤0.01%	1596

Other funds holding YCBD

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return

Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

SCA

Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GSA Capital Partners's YCBD Position: Q3 2025 in Review

GSA Capital Partners sold out of cbdMD (YCBD) in Q3 2025, closing a stake of 37,465 shares — an estimated $33K sold.

GSA Capital Partners first reported a position in YCBD in Q1 2025 and held it in 2 quarters. The position peaked at $33K in Q2 2025. 20 funds tracked by Wall St. Rank hold YCBD as of Q3 2025.

GSA Capital Partners reported no remaining cbdMD position as of Q3 2025 after selling out during the quarter.
GSA Capital Partners sold 37,465 cbdMD shares in Q3 2025, an estimated $33K.
GSA Capital Partners first reported a position in cbdMD in Q1 2025 and held it in 2 quarters.
GSA Capital Partners's cbdMD position peaked at $33K in Q2 2025.
20 funds tracked by Wall St. Rank held cbdMD as of Q3 2025.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.